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ing category of AF. This result was seen with MRI scans ac-
quired at multiple participating centers worldwide with
differingprocedural approachesandablation techniquesused.
Establishing a patient’s left atrial fibrosis burden offers one of
the fewoutcomedeterminants that couldbeused in the clinic
when counseling patients on whether theymay benefit from
ablation therapy.
Drs Tops andSchalij raise questions related to the stage of
fibrosis and duration of fibrillation in patients with paroxys-
mal AF and their outcomes after ablation. Even though pa-
tients with paroxysmal AF have been considered to have less
advanced disease, the DECAAF results challenge the clinical
conventionsusedtoassess leftatrialdisease.Asignificantnum-
ber of patients with paroxysmal AF presentedwith advanced
atrial fibrosis stage.
Although establishing the onset and duration of AF re-
mains challenging, in part due to the high percentage of pa-
tients with asymptomatic arrhythmia, AF duration reported
in DECAAF did not correlate with the degree of atrial fibrosis
(correlation coefficient, 0.02; P = .71).With delayed enhance-
mentMRI, inferencesaboutdiseaseburdenmayno longerneed
to rely solely on routine AF typing.
Theassociationbetweenatrial fibrosisandAFhasbeenwell
described inhistological studies.Evidencevalidating left atrial
fibrosisquantificationonMRI ismountingwithcompellinghis-
tological, electrical, and clinical data.1-3 Detection ofmyocar-
dial injury and remodeling using delayed enhancement MRI
sequences isawell-validatedtechniquedatingback to the land-
markhistological studybyKimet al,4whichhelped launchde-
layedenhancementMRI as the criterion standard for tissuevi-
ability testing.
We agree that patient selection criteria for AF ablation
shouldnotbedecidedbyanyoneparameter alone. Studiesde-
signed to improveunderstandingof the interplaybetween the
left atrial structural, functional, andelectrophysiological pro-
cesses thatunderlieAFareneeded toadvance theunderstand-
ing of AF pathophysiology.
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Economic Incentives andUse
of the Intensive Care Unit
To theEditorDrsGoochandKahn1pointedout an intriguingex-
ample of economic incentives driving widely varying inten-
sive care unit (ICU) admission criteria. However, their con-
cept of “demand elasticity” conflated 2 distinct economic
phenomena, normal demand and supplier-induced demand,
leading them to a draconian policy prescription.
In classic economics, consumers might demand care of
little benefit if they are insulated from the cost through
insurance, but they will never demand harmful care, such
as ICU care for patients with high-illness severity and low
survival in the conceptual model. Increased ICU bed avail-
ability could only cause increased harm in the presence of
supplier-induced demand; eg, when a clinician or hospital
system profits by advising a less-informed patient to con-
sume services the patient would not want if he or she knew
all the facts.2
Demonstrating the existence of induced demand is con-
troversial and requires cautious investigation of a change in
profitability, causingachange inthevolumeofcareconsumed.3
In addition, for demand to be induced, the evaluating physi-
cianmust be concernedwith the hospital's profit frommain-
taining full ICU capacity. Anecdotally, intensivists are often
frustratedbypatient and familydemands for futile care,which
argues against the induced-demand explanation.
Normaldemand is sufficient toexplainwhyadmissioncri-
teriamight vary according to bed availability. Appropriate pa-
tients benefit most from critical care; however, many pa-
tients admitted for observation still benefit, albeit to a lesser
degree. Compared with the relatively fixed costs of facilities
andsalary, theadditional costs of observing 1morepatient can
be low.
As long as the benefit exceeds the additional cost of fill-
ing an otherwise empty bed, ICU admission criteria should
change based on bed availability. The conceptual model de-
picted in theViewpoint as pathological is actually an efficient
waytodeliverhigh fixed-cost services, justasairlinesvary their
prices to keep airplanes full.
Whether supplier-induced demand or normal demand
drives ICU use, it remains questionable whether beds are the
causeofhighutilizationrather thanasymptom. It ismore likely
thatunderlyinghighdemand for ICUservices causesbothcon-
struction of many beds and the filling of those beds.
Therefore, the fault lieswithapricing systemthatdoesnot
differentiate sufficiently between patients who benefit more
than the cost and those who do not. If necessary, paying less
for inappropriate patients and more for appropriate patients
would shift use away from less sickpatients, causingmore ap-
propriate ICU usage without resorting to potentially harmful
bed quotas.
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In Reply We did not argue that ICU admission directly harms
patients with low illness severity. Our Viewpoint acknowl-
edged a small potential benefit of close observation in the ICU
for thesepatients.Therefore,wedidnotuse the termsupplier-
induceddemand,which, asMr Friedman correctly notes, im-
plies but does not require a lack ofmarginal benefit.1 Instead,
weargued that this small potential benefit doesnot justify the
high costs of building andmaintaining ICUs.
The idea thatexcess ICUbedsupply leads tooveruse iswell
supported by data, both old2 and new.3 Friedman’s sugges-
tion that current use patterns represent an efficient use of re-
sources lacks the same evidentiary support. Moreover, al-
though it is true that ICU beds carry high fixed costs, and
therefore the costs to individual patients are low, we did not
propose simply not admitting low-risk patients.Weproposed
closing ICU beds and thus, substantially lowering fixed costs.
Friedman’salternativesolutionofvarying ICUpricesbased
on appropriateness is intriguing but impractical. It would re-
quire accurate and reliable assessment of ICU appropriate-
ness, which is currently impossible4; and it would lead to ex-
plicit rationingby ability topay,which is ethically untenable.5
Our solution is to trust the innate ability of physicians to per-
form safe implicit rationing in the setting of constrained
supply,6maintaining qualitywhile reducing the costs of care.
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CORRECTION
Omitted Author Affiliations: In the Original Investigation entitled “Radiofre-
quency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal
AtrialFibrillation(RAAFT-2):ARandomizedTrial”published in theFebruary 19,2014,
issue of JAMA (2014;311[7]:692-699. doi:10.1001/jama.2014.467), the author af-
filiations were omitted. This article was corrected online.
IncorrectReferenceCitation: In theHealthAgenciesUpdatearticleentitled“More
Accurate Autism Screening,” published in the February 26, 2014, issue of JAMA
(2014;311[8]:791. doi:10.1001/jama.2014.1340), a referencewas citedwith the in-
correct firstauthor.ThereferenceshouldhavereadRobinsDLetal.Pediatrics. 2014;
133(1):37-45. This article has been corrected online.
Error in Title: In the Capitol Health Call article entitled “Where Medicare Health
Dollars Go,” published in the April 9, 2014, issue of JAMA (2014;311[14]:1389. doi:
10.1001/jama.2014.3710), thetitle referredtothe incorrectprogram.Thetitleshould
have read, “WhereMedicaidHealthDollarsGo.”This articlehasbeencorrectedon-
line.
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